Cannabinoids, Automated Oral Fluid Assay (70 mL)

The Intercept® i2he™ Cannabinoids Oral Fluid Assay is intended for use in the qualitative determination of Cannabinoids in human oral fluid at a cutoff concentration of 3 ng/mL in neat oral fluid. The specimen must be collected exclusively with the Intercept® i2he™ Oral Fluid Collection Device. The assay is calibrated against l-∆9 tetrahydrocannabinol (l- isomer ∆9 THC) and performed on clinical chemistry analyzers. This device is not intended for use for clinical diagnostic applications. The Intercept® i2he™ Cannabinoids Oral Fluid Assay provides only a preliminary analytical test result. A more specific alternative method must be used to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) are the preferred confirmatory methods.(1-2) Clinical consideration and professional judgment should be applied to any drug of abuse test result particularly when preliminary positive results are used.